Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.5843
+0.0193 (3.42%)
Aug 8, 2025, 3:57 PM EDT
Elite Pharmaceuticals Market Cap
Elite Pharmaceuticals has a market cap or net worth of $625.65 million as of August 8, 2025. Its market cap has increased by 205.03% in one year.
Market Cap
625.65M
Enterprise Value
625.25M
Revenue
84.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.58
Market Cap Chart
Since July 23, 1998, Elite Pharmaceuticals's market cap has increased from 9.58M to 625.65M, an increase of 6,434.02%. That is a compound annual growth rate of 16.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 625.65M | 8.24% |
| Dec 31, 2024 | 578.04M | 306.60% |
| Dec 29, 2023 | 142.16M | 374.74% |
| Dec 30, 2022 | 29.95M | -10.40% |
| Dec 31, 2021 | 33.42M | -36.49% |
| Dec 31, 2020 | 52.63M | -31.72% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Glass House Brands | 497.52M |
| Northwest Biotherapeutics | 366.75M |
| American Oncology Network | 353.52M |
| CytoDyn | 322.85M |
| Alterola Biotech | 296.25M |